Imitrex vs. Emgality
See how Imitrex and Emgality compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Imitrex is taken at the first sign of a migraine to stop an attack already underway, while Emgality is injected monthly to prevent migraines before they start.
Imitrex can relieve pain within about an hour, but Emgality's preventive benefit builds gradually over the first few months of treatment.
Imitrex has cardiovascular contraindications that rule it out for some patients, while Emgality carries no boxed warning but can worsen Raynaud's phenomenon.
Imitrex vs. Emgality Drug Summary
Imitrex
Imitrex is a triptan (5-HT1B/1D receptor agonist) used for the acute treatment of migraine attacks and cluster headaches. It's taken as a tablet at the first sign of a migraine, with a second dose allowed after two hours if needed. It only stops a migraine already underway; it isn't used to prevent them.
Emgality
Emgality is a CGRP-antagonist monoclonal antibody used to prevent migraines and episodic cluster headaches before they start. It's given as a once-monthly self-injection, starting with a double loading dose in month one. It doesn't treat a migraine that has already begun.
Imitrex vs. Emgality Side Effects
Imitrex
Emgality
Imitrex vs. Emgality Dosage
Imitrex
Emgality
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg, 50 mg, or 100 mg | At the start |
| Maximum dose | Repeat dose, max 200mg/day | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 240 mg | Day 1 |
| Maximum dose | 300 mg once monthly | If needed |
| Dose changes | 2 increases | As tolerated |
Imitrex
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg, 50 mg, or 100 mg | At the start |
| Maximum dose | Repeat dose, max 200mg/day | If needed |
| Dose changes | 1 increase | As tolerated |
Emgality
| STAGE | DOSE | WHEN |
| Starting dose | 240 mg | Day 1 |
| Maximum dose | 300 mg once monthly | If needed |
| Dose changes | 2 increases | As tolerated |
Imitrex vs. Emgality Indications
Imitrex
Imitrex is FDA-approved for the acute treatment of migraine, with or without aura, in adults. It's also approved as an injection for acute cluster headache attacks. It is meant to stop a migraine that has already started, not to prevent future ones.
Acute treatment of migraine attacks, with or without aura, in adults
Acute treatment of cluster headache (injection form only)
Used to stop a migraine already in progress, not to prevent one
Available as tablet, nasal spray, or injection for different speeds of relief
Emgality
Emgality is FDA-approved for the preventive treatment of migraine in adults, reducing how often attacks occur. It's also approved to treat episodic cluster headache. It is not used to treat a migraine once it has already started.
Preventive treatment to reduce migraine frequency in adults
Treatment of episodic cluster headache in adults
Given monthly to head off attacks before they begin
Not used for treating a migraine that has already started
Imitrex vs. Emgality Pros and Cons
Imitrex
Imitrex has a long track record for stopping migraine pain quickly, backed by decades of real-world use. Its cardiovascular contraindications mean it isn't suitable for people with heart disease, uncontrolled blood pressure, or a history of stroke.
Pros
Works fast, often within an hour, for a migraine already underway
Available in tablet, nasal spray, and injection forms for flexible dosing
Decades of real-world use with well-established safety data
Can be redosed the same day if migraine symptoms return
Cons
Not approved for migraine prevention, only for acute attacks
Contraindicated in people with heart disease, stroke history, or uncontrolled high blood pressure
Cannot be combined with another triptan or ergot medicine within 24 hours
Carries a risk of serotonin syndrome when combined with SSRIs or SNRIs
Emgality
Emgality is built for prevention, cutting down how many migraines happen each month rather than treating one already in progress. Its main tradeoff is that it offers no benefit for an attack that's already underway, and injection site reactions are common.
Pros
Designed specifically to prevent migraines, reducing how often they occur
Only needs to be injected once a month
No boxed warning and no cardiovascular contraindications like triptans
Also approved to prevent episodic cluster headache attacks
Cons
Does not treat a migraine once it has already started
Can cause new or worsening Raynaud's phenomenon
Requires an initial double-dose injection to build up levels
Injection site reactions are common, affecting up to 18% of users
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.